• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化在时间和空间上——病因的地理线索

Multiple sclerosis in time and space--geographic clues to cause.

作者信息

Kurtzke J F

机构信息

Neuroepidemiology Section, Veterans Affairs Medical Center, Washington DC, USA.

出版信息

J Neurovirol. 2000 May;6 Suppl 2:S134-40.

PMID:10871801
Abstract

Geographically MS describes three frequency zones. High frequency areas (prevalence 30+ per 100 000) now comprise most of Europe, Israel, Canada, northern US, southeastern Australia, New Zealand, and easternmost Russia. Medium frequency areas include southern US, most of Australia, South Africa, the southern Mediterranean basin, Russia into Siberia, the Ukraine and parts of Latin America. Prevalence rates under 5 per 100 000 are found in the rest of Asia, Africa and northern South America. Migrants from high to lower risk areas retain the MS risk of their birth place only if they are at least age 15 at migration. Those from low to high increase their risk even beyond that of the natives, with susceptibility extending from about age 11 to 45. Thus MS is ordinarily acquired in early adolescence with a lengthy latency before symptom onset. MS occurred in epidemic form in North Atlantic islands: probably in Iceland and the Shetland-Orkneys; clearly in the Faroe Islands. In the Faroes first symptom onset was in 1943, heralding the first of four successive epidemics at 13 year intervals. The disease was presumably introduced by occupying British troops during World War II, with the postwar occurrences representing later transmissions to and from consecutive cohorts of Faroese. What was transmitted is thought to be a specific, widespread, persistent infection called PMSA (the primary multiple sclerosis affection) which only rarely leads years later to clinical MS. Search for PMSA is best attempted on the Faroes where there are regions still free of MS after 50 years.

摘要

从地理分布来看,多发性硬化症呈现出三个发病频率区域。高频区域(每10万人中患病率达30及以上)如今涵盖了欧洲大部分地区、以色列、加拿大、美国北部、澳大利亚东南部、新西兰以及俄罗斯最东部地区。中频区域包括美国南部、澳大利亚大部分地区、南非、地中海盆地南部、俄罗斯直至西伯利亚、乌克兰以及拉丁美洲部分地区。在亚洲其他地区、非洲以及南美洲北部,每10万人中患病率低于5。从高风险区域迁移至低风险区域的移民,只有在15岁及以上移民时才会保留其出生地患多发性硬化症的风险。从低风险区域迁移至高风险区域的移民,其患病风险甚至会超过当地居民,易感性从11岁左右持续至45岁左右。因此,多发性硬化症通常在青春期早期感染,在症状出现前有很长的潜伏期。多发性硬化症曾在北大西洋岛屿呈流行形式出现:可能在冰岛以及设得兰群岛 - 奥克尼群岛;在法罗群岛则很明显。在法罗群岛,首例症状出现在1943年,随后每隔13年出现一次连续四次的流行疫情。据推测,这种疾病是在第二次世界大战期间由占领该地的英国军队传入的,战后的病例代表了法罗群岛连续几代人之间的后续传播。据认为传播的是一种特定的、广泛存在且持续的感染,称为PMSA(原发性多发性硬化症感染源),这种感染很少在数年之后导致临床多发性硬化症。在法罗群岛进行寻找PMSA的研究最为适宜,那里有一些地区在50年后仍未出现多发性硬化症病例。

相似文献

1
Multiple sclerosis in time and space--geographic clues to cause.多发性硬化在时间和空间上——病因的地理线索
J Neurovirol. 2000 May;6 Suppl 2:S134-40.
2
MS epidemiology in Faroe Islands.法罗群岛的多发性硬化症流行病学
Riv Neurol. 1987 Mar-Apr;57(2):77-87.
3
Epidemiology and etiology of multiple sclerosis.
Phys Med Rehabil Clin N Am. 2005 May;16(2):327-49. doi: 10.1016/j.pmr.2005.01.013.
4
Multiple sclerosis in the Faroe Islands. 5. The occurrence of the fourth epidemic as validation of transmission.法罗群岛的多发性硬化症。5. 第四次疫情的发生作为传播的验证。
Acta Neurol Scand. 1993 Sep;88(3):161-73.
5
Multiple sclerosis in the Faroe Islands: an epitome.法罗群岛的多发性硬化症:一个缩影。
J Clin Epidemiol. 2001 Jan;54(1):1-22. doi: 10.1016/s0895-4356(00)00268-7.
6
Epidemiology in multiple sclerosis: a pilgrim's progress.多发性硬化症的流行病学:一个朝圣者的历程。
Brain. 2013 Sep;136(Pt 9):2904-17. doi: 10.1093/brain/awt220.
7
Validity of the epidemics of multiple sclerosis in the Faroe Islands.
Neuroepidemiology. 1988;7(4):190-227. doi: 10.1159/000110154.
8
A reassessment of the distribution of multiple sclerosis. Part one.多发性硬化症分布的重新评估。第一部分。
Acta Neurol Scand. 1975 Feb;51(2):110-36. doi: 10.1111/j.1600-0404.1975.tb01364.x.
9
Multiple sclerosis in the Faroe Islands: transmission across four epidemics.
Acta Neurol Scand. 1995 May;91(5):321-5. doi: 10.1111/j.1600-0404.1995.tb07015.x.
10
Epidemiologic evidence for multiple sclerosis as an infection.多发性硬化症作为一种感染性疾病的流行病学证据。
Clin Microbiol Rev. 1993 Oct;6(4):382-427. doi: 10.1128/CMR.6.4.382.

引用本文的文献

1
Previous epidemiological studies support the idea of ileal microbiota triggering multiple sclerosis.先前的流行病学研究支持回肠微生物群引发多发性硬化症这一观点。
Proc Natl Acad Sci U S A. 2025 Jul 29;122(30):e2514491122. doi: 10.1073/pnas.2514491122. Epub 2025 Jul 21.
2
Advancements in multiple sclerosis.多发性硬化症的进展
Intern Med J. 2025 Jun;55(6):895-904. doi: 10.1111/imj.70023. Epub 2025 Apr 2.
3
Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis.奥瑞珠单抗治疗伊朗复发型多发性硬化症患者的成本效益
Curr J Neurol. 2021 Jul 6;20(3):154-161. doi: 10.18502/cjn.v20i3.7691.
4
Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk.在接受奥瑞珠单抗治疗的复发型多发性硬化症患者中评估BAFF、APRIL和CD40L以及感染风险。
Biology (Basel). 2023 Apr 12;12(4):587. doi: 10.3390/biology12040587.
5
Burden and trends of multiple sclerosis in China from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.中国 1990 年至 2019 年多发性硬化症负担和趋势:2019 年全球疾病负担研究的系统分析。
BMJ Open. 2022 Dec 8;12(12):e066335. doi: 10.1136/bmjopen-2022-066335.
6
FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis.未来 MS 队列特征:苏格兰多中心首发队列研究多发性硬化症复发缓解型。
BMJ Open. 2022 Jun 29;12(6):e058506. doi: 10.1136/bmjopen-2021-058506.
7
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study.接受疾病修正治疗的多发性硬化症患者的感染风险:一项为期三年的观察性队列研究。
Mult Scler J Exp Transl Clin. 2022 Jan 4;8(1):20552173211065731. doi: 10.1177/20552173211065731. eCollection 2022 Jan-Mar.
8
Clinical Pathway for the Diagnosis and Management of Patients With Relapsing-Remitting Multiple Sclerosis: A First Proposal for the Peruvian Population.复发缓解型多发性硬化症患者诊断与管理的临床路径:秘鲁人群的初步建议
Front Neurol. 2021 Oct 21;12:667398. doi: 10.3389/fneur.2021.667398. eCollection 2021.
9
Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria.脱髓鞘疾病患者的脑脊液 IgG 抗体与多发性硬化症相关细菌结合。
J Mol Med (Berl). 2021 Oct;99(10):1399-1411. doi: 10.1007/s00109-021-02085-z. Epub 2021 Jun 8.
10
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist.视神经脊髓炎谱系疾病(NMOSD)与结缔组织病(CTD):风湿病医生的最新认识。
Curr Rheumatol Rep. 2021 Apr 28;23(6):33. doi: 10.1007/s11926-021-01000-2.